124 related articles for article (PubMed ID: 10760201)
1. In vitro properties of red cells prepared from half-strength citrate CPD/RAS-2 (Erythro-sol) donations in PL-146 plastic.
Hornsey VS; MacDonald S; Drummond O; Bethel H; Walker B; Prowse CV
Transfus Med; 2000 Mar; 10(1):31-5. PubMed ID: 10760201
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system.
Högman CF; Eriksson L; Wallvik J; Payrat JM
Vox Sang; 1997; 73(4):212-9. PubMed ID: 9407638
[TBL] [Abstract][Full Text] [Related]
3. Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood.
Solheim BG; Bergerud UE; Kjeldsen-Kragh J; Brosstad F; Mollnes TE; Högman CF; Eriksson L; Schutz R
Vox Sang; 1998; 74(3):168-75. PubMed ID: 9595644
[TBL] [Abstract][Full Text] [Related]
4. Half-strength citrate CPD and new additive solutions for improved blood preservation. I. Studies of six experimental solutions.
Högman CF; Eriksson L; Gong J; Payrat JM; Debrauwere J
Transfus Med; 1993 Mar; 3(1):43-50. PubMed ID: 8038896
[TBL] [Abstract][Full Text] [Related]
5. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant.
Prowse C; Waterston YG; Dawes J; Farrugia A
Vox Sang; 1987; 52(4):257-64. PubMed ID: 3114954
[TBL] [Abstract][Full Text] [Related]
6. Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant.
Suontaka AM; Akerblom O; Blombäck M; Eriksson L; Högman CF; Payrat JM
Vox Sang; 1996; 71(2):97-102. PubMed ID: 8873419
[TBL] [Abstract][Full Text] [Related]
7. Studies on the procurement of blood coagulation factor VIII. In vitro studies on blood components prepared in half-strength citrate anticoagulant 18 hours after phlebotomy.
Griffin B; Bell K; Prowse C
Vox Sang; 1988; 55(1):9-13. PubMed ID: 3138819
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial of red-cell concentrate prepared from blood collected in half-strength citrate anticoagulant.
Murphy WG; Palmer JB; Wilson R; Prowse CV; McClelland DB
Transfus Med; 1991 Mar; 1(1):25-9. PubMed ID: 9259823
[TBL] [Abstract][Full Text] [Related]
9. Red cell and platelet concentrates from blood collected into half-strength citrate anticoagulant: improved maintenance of red cell 2,3-diphosphoglycerate in half-citrate red cells.
Farrugia A; Douglas S; James J; Whyte G
Vox Sang; 1992; 63(1):31-8. PubMed ID: 1413661
[TBL] [Abstract][Full Text] [Related]
10. Improved maintenance of 2,3 DPG and ATP in RBCs stored in a modified additive solution.
Högman CF; Knutson F; Lööf H; Payrat JM
Transfusion; 2002 Jul; 42(7):824-9. PubMed ID: 12375653
[TBL] [Abstract][Full Text] [Related]
11. Shall red cell units stand upright, lie flat or be mixed during storage? In vitro studies of red cells collected in 0.5 CPD and stored in RAS2 (Erythrosol).
Högman CF; Eriksson L; Gong J; Högman AB; Payrat JM
Transfus Sci; 1995 Jun; 16(2):193-9. PubMed ID: 10155740
[TBL] [Abstract][Full Text] [Related]
12. Buffy-coat-derived platelet concentrates prepared from half-strength citrate CPD and CPD whole-blood units. Comparison between three additive solutions: in vitro studies.
Gulliksson H; Eriksson L; Högman CF; Payrat JM
Vox Sang; 1995; 68(3):152-9. PubMed ID: 7625071
[TBL] [Abstract][Full Text] [Related]
13. Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use.
Högman CF; Eriksson L; Gong J; Högman AB; Vikholm K; Debrauwere J; Payrat JM; Stewart M
Vox Sang; 1993; 65(4):271-8. PubMed ID: 8310679
[TBL] [Abstract][Full Text] [Related]
14. Stability of red cell antigens and plasma coagulation factors stored in new formulation plastic blood containers.
Snyder EL; Hezzey A; Weirich F; Mosher DF; Davisson W; Buchholz DH
Transfusion; 1983; 23(1):49-53. PubMed ID: 6829059
[TBL] [Abstract][Full Text] [Related]
15. Whole blood storage in citrate and phosphate solutions containing half-strength trisodium citrate: cellular and biochemical studies.
Mishler JM; Darley JH; Cederholm-Williams S; Wright G
J Pathol; 1978 Mar; 124(3):125-39. PubMed ID: 722376
[TBL] [Abstract][Full Text] [Related]
16. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
Beutler E; West C
J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
[TBL] [Abstract][Full Text] [Related]
17. Red cell storage in E-Sol 5 and Adsol additive solutions: paired comparison using mixed and non-mixed study designs.
Radwanski K; Thill M; Min K
Vox Sang; 2014 May; 106(4):322-9. PubMed ID: 24164372
[TBL] [Abstract][Full Text] [Related]
18. Studies on the procurement of blood coagulation factor VIII. In vivo studies on blood components prepared in half-strength citrate anticoagulant.
Griffin B; Bell K; Prowse C
Vox Sang; 1988; 54(4):193-8. PubMed ID: 3133879
[TBL] [Abstract][Full Text] [Related]
19. Collection and storage of red blood cells with anticoagulant and additive solution with a physiologic pH.
Burger P; Korsten H; Verhoeven AJ; de Korte D; van Bruggen R
Transfusion; 2012 Jun; 52(6):1245-52. PubMed ID: 22233266
[TBL] [Abstract][Full Text] [Related]
20. The in vivo survival of red blood cells stored in modified CPD with adenine: report of a multi-institutional cooperative effort.
Zuck TF; Bensinger TA; Peck CC; Chillar RK; Beutler E; Button LN; McCurdy PR; Josephson AM; Greenwalt TJ
Transfusion; 1977; 17(4):374-82. PubMed ID: 878003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
